microdosing tirzepatide weight loss Chart: A Weekly Dose Guide That Works Thinking About Microdosing GLP-1? 5

Phase 2 trial data (NEJM, 2023) reported a mean body weight reduction of approximately 24% over 48 weeks at the highest dose, though larger Phase 3 trials are needed to confirm these findings

Missing the mark in either direction can lead to serious consequences

A good product produced by a reliable clinic in association with a quality pharmacist resulting in a product that is reliable, safe, and effective

The minimum shelf life applies to the undamaged and properly stored product

In some cases, healthcare providers may recommend using approved GLP-1 medications alongside bariatric surgery to enhance weight loss outcomes

This implies that weight loss maintenance with GLP-1RA may act to prevent pre-diabetes in obesity